
Astec Lifesciences Q2 FY27 Results: Consolidated Net Loss ₹37.40 Crore on Total Income of ₹72.64 Crore
Astec Lifesciences (NSE: ASTEC) reported consolidated total income of ₹72.64 crore and a net loss of ₹37.40 crore for the quarter ended 30 Sep 2026, it said in a filing on 26 Oct 2026. Standalone total income was ₹72.62 crore and the standalone net loss was ₹37.43 crore.
- Earnings
- agrochemicals